BioSpace News Archive

Business

NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research

NeuroVive today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research for an Industrial PhD to study the role of cyclophilins in liver cancer.

October 18, 2017

·

4 min read

Drug Development

AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

AMO Pharma presented positive interim analysis of data from the first cohort of its study of AMO-02 in congenital myotonic dystrophy.

October 18, 2017

·

3 min read

Deals

Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery

Bracco Imaging today announced the acquisition of SurgVision, a high-tech start-up focused on developing a real-time Fluorescence Image Guided Surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

October 18, 2017

·

4 min read

BioMidwest

PH&S Products Release: Testing Confirms Fentanyl-Resistant Glove

PH&S Products received notification from the ARDL that its ResQ-Grip premium nitrile examination grade gloves were successfully tested for resistance to fentanyl.

October 18, 2017

·

2 min read

FDA

Innovus Pharma Receives Approval From Health Canada for Vesele as a Natural Health Product

Innovus Pharma announced that it has received approval from Health Canada to market its best-selling, clinically proven Vesele product as a Natural Health Product (“NHP”) to help improve nitric oxide production involved in symptoms of sexual dysfunction.

October 18, 2017

·

4 min read

A Personal Letter to the Shareholders From TapImmune’s New Chief Executive Officer

TapImmune announces a letter from the CEO.

October 18, 2017

·

7 min read

Policy

FDA Accepts Regulatory Submission for AstraZeneca’s LYNPARZA (Olaparib) in Metastatic Breast Cancer and Grants Priority Review

LYNPARZA has the potential to offer a new treatment option for patients with germline BRCA-mutated, HER2-negative metastatic breast cancer.

October 18, 2017

·

13 min read

Drug Development

Merck’s KEYTRUDA (Pembrolizumab) More Than Doubled Median Overall Survival Compared To Chemotherapy After Two Years Of Follow Up In First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer With High Levels Of PD-L1

Merck announced the presentation of updated overall survival (OS) findings, a secondary endpoint, from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA (pembrolizumab).

October 18, 2017

·

27 min read

Business

Dr. Jan Van De Winkel Joins Hookipa As Chairman Of Its Board Of Directors

Hookipa Biotech, a company pioneering an innovative class of immunotherapies for oncology and infectious diseases, today announced the appointment of Dr. Jan van de Winkel as Chairman of its Board of Directors.

October 18, 2017

·

4 min read

Drug Development

BioLineRx Announces Initiation of Phase Ib/2 Trial for BL-80040 in Gastric Cancer Under Immunotherapy Collaboration

BioLineRx announced today that Genentech has commenced a Phase 1b/2 study for the treatment of gastric cancer with BL-8040 in combination with atezolizumab, Genentech’s anti-PDL1 cancer immunotherapy agent.

October 18, 2017

·

6 min read